08:49 AM EST, 11/12/2024 (MT Newswires) -- Centessa Pharmaceuticals ( CNTA ) reported a Q3 loss Tuesday of $0.37 per diluted share, wider than a loss of $0.40 a year earlier.
Analysts polled by Capital IQ expected a loss of $0.41.
As of September 30, cash and cash equivalents were $518.4 million, which is expected to fund operations into mid-2027.